Tibet Weixinkang Medicine Co., Ltd.

SHSE:603676 Stock Report

Market Cap: CN¥4.5b

Tibet Weixinkang Medicine Balance Sheet Health

Financial Health criteria checks 6/6

Tibet Weixinkang Medicine has a total shareholder equity of CN¥1.5B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.9B and CN¥451.2M respectively. Tibet Weixinkang Medicine's EBIT is CN¥195.6M making its interest coverage ratio -9.8. It has cash and short-term investments of CN¥1.1B.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ratio-9.8x
CashCN¥1.06b
EquityCN¥1.48b
Total liabilitiesCN¥451.24m
Total assetsCN¥1.93b

Recent financial health updates

No updates

Recent updates

With EPS Growth And More, Tibet Weixinkang Medicine (SHSE:603676) Makes An Interesting Case

Oct 01
With EPS Growth And More, Tibet Weixinkang Medicine (SHSE:603676) Makes An Interesting Case

Concerns Surrounding Tibet Weixinkang Medicine's (SHSE:603676) Performance

Sep 03
Concerns Surrounding Tibet Weixinkang Medicine's (SHSE:603676) Performance

Take Care Before Diving Into The Deep End On Tibet Weixinkang Medicine Co., Ltd. (SHSE:603676)

Apr 16
Take Care Before Diving Into The Deep End On Tibet Weixinkang Medicine Co., Ltd. (SHSE:603676)

Financial Position Analysis

Short Term Liabilities: 603676's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥406.7M).

Long Term Liabilities: 603676's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥44.5M).


Debt to Equity History and Analysis

Debt Level: 603676 is debt free.

Reducing Debt: 603676 has no debt compared to 5 years ago when its debt to equity ratio was 8%.

Debt Coverage: 603676 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 603676 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies